Back to results
US 12,559,750 B2Granted
Methods and compositions for treatment of polycystic kidney disease
AssigneeRegulus Therapeutics Inc.
InventorsDenis Drygin, Garth A. Kinberger, Edmund Chun Yu Lee
Life of this patent
Estimating the term…
Abstract
Provided herein are methods for the treatment of polycystic kidney disease, including autosomal dominant polycystic kidney disease, using modified oligonucleotides targeted to miR-17.
Claims15
A modified oligonucleotide having the structure:
- or a pharmaceutically acceptable salt thereof.
A modified oligonucleotide having the structure:
Dependencies are inferred from the claim text.